On Wednesday, the U.S. Food and Drug Administration (FDA) granted approval for IMAAVY™ (nipocalimab-aahu), Johnson & ...

The White House is unveiling President Donald Trump’s 2026 budget, a sweeping framework proposing steep reductions in ...

Gene therapy has emerged as a promising approach to previously untreatable conditions, including Duchenne muscular dystrophy (DMD), a progressive disorder caused by DMD mutations that leads to early ...

Trader Joe’s Sesame Miso Salad with Salmon was recalled because of a possible milk allergen. The affected batch has use by ...

QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, ...

The U.S. Food and Drug Administration is asking some of its recently fired staff responsible for critically important funding ...

Study participants were randomly assigned 2:1 to receive oral semaglutide 25mg (n=205) or placebo (n=102), as an adjunct to lifestyle intervention. The coprimary endpoints were the relative change in ...

The FDA has rehired at least some workers tasked with releasing public records generated by the agency’s regulatory ...

A decision is expected in the fourth quarter of 2025.

The week of April 28, 2025, saw four major food recalls over undeclared allergens and foreign object contamination. Here's ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...